28744 Federal Register / Vol. 79, No. 96 / Monday, May 19, 2014 / Notices 

Health, 6701 Rockledge Drive, Room 4146, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1016, wangca@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Health Disparities and Equity Promotion 

Study Section. 

Date: June 12–13, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Wyndham Grand RiverFront, 71 E 

Wacker Drive, Chicago, IL 60601. 

Contact Person: Delia Olufokunbi Sam, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3158, 

MSC 7770, Bethesda, MD 20892, 301–435– 

0684, olufokunbisamd@csr.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group; 

Atherosclerosis and Inflammation of the 

Cardiovascular System Study Section. 

Date: June 12–13, 2014. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Natalia Komissarova, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5207, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1206, komissar@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Cancer Diagnostics and 

Treatments. 

Date: June 12–13, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Zhang-Zhi Hu, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6186, 

MSC 7804, Bethesda, MD 20892, (301) 594– 

2414, huzhuang@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Biomedical 

Imaging and Engineering Area Review. 

Date: June 12, 2014. 

Time: 11:45 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Mehrdad Mohseni, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5211, 

MSC 7854, Bethesda, MD 20892, 301–435– 

0484, mohsenim@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Mechanisms 

of Neurodegeneration. 

Date: June 12, 2014. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Palomar, 2121 P Street NW., 

Washington, DC 20037. 

Contact Person: Carole L Jelsema, Ph.D., 

Chief and Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4176, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1248, jelsemac@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR13–345: 

Development of Appropriate Pediatric 

Formulations. 

Date: June 12, 2014. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Yuan Luo, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5207, MSC 7846, Bethesda, MD 

20892, 301–915–6303, luoy2@mail.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group; 

Urologic and Genitourinary Physiology and 

Pathology. 

Date: June 13, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Washington National 

Airport, 1489 Jefferson Davis Hwy, Arlington, 

VA 22202. 

Contact Person: Ryan G Morris, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4205, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1501, morrisr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Basic and Integrative 

Bioengineering. 

Date: June 13, 2014. 

Time: 11:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: David R Filpula, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6181, 

MSC 7892, Bethesda, MD 20892, 301–435– 

2902, filpuladr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 13, 2014. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–11454 Filed 5–16–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; Clinical 

Trials Outcome Development. 

Date: June 12, 2014. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Suite 800, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Xincheng Zheng, MD, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute of 

Arthritis, Musculoskeletal and Skin Diseases, 

NIH, 6701 Democracy Boulevard, Suite 800, 

Bethesda, MD 20892, 301–594–4953, 

xincheng.zheng@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: May 13, 2014. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–11458 Filed 5–16–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2013–0032] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request; Generic Clearance 

for the Collection of Qualitative 

Feedback on Agency Service Delivery 

AGENCY: National Protection and 

Programs Directorate, DHS. 

ACTION: 30-Day notice of submission of 

information collection approval from 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 96 / Monday, May 19, 2014 / Notices 28745 

the Office of Management and Budget 

and request for comments. 

SUMMARY: As part of a Federal 

Government-wide effort to streamline 

the process to seek feedback from the 

public on service delivery, the 

Department of Homeland Security 

(DHS), National Protection and 

Programs Directorate (NPPD), Office of 

the Chief Information Office has 

submitted a Generic Information 

Collection Request (Generic ICR): 

‘‘Generic Clearance for the Collection of 

Qualitative Feedback on Agency Service 

Delivery’’ to OMB for approval under 

the Paperwork Reduction Act (PRA) (44 

U.S.C. 3501 et. seq.). 

DATES: Comments are encouraged and 

will be accepted until June 18, 2014. 

This process is conducted in accordance 

with 5 CFR 1320.10. 

ADDRESSES: Written comments may be 

submitted to the Office of Information 

and Regulatory Affairs, OMB. 

Comments should be addressed to OMB 

Desk Officer, DHS, Office of Civil Rights 

and Civil Liberties. Comments must be 

identified by DHS–2013–0032 and may 

be submitted by one of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. 

• Email: oira_submission@

omb.eop.gov. Include the docket 

number in the subject line of the 

message. 

• Fax: (202) 395–5806 

Instructions: All submissions received 

must include the words ‘‘Department of 

Homeland Security’’ and the docket 

number for this action. Comments 

received will be posted without 

alteration at http://www.regulations.gov, 

including any personal information 

provided. 

FOR FURTHER INFORMATION CONTACT: To 

request additional information, please 

Contact: DHS/NPPD, Office of the Chief 

Information Office, nppd-prac@

hq.dhs.gov. 

SUPPLEMENTARY INFORMATION: 

Title: Generic Clearance for the 

Collection of Qualitative Feedback on 

Agency Service Delivery. 

Abstract: The proposed information 

collection activity provides a means to 

garner qualitative customer and 

stakeholder feedback in an efficient, 

timely manner, in accordance with the 

Administration’s commitment to 

improving service delivery. By 

qualitative feedback we mean 

information that provides useful 

insights on perceptions and opinions, 

but are not statistical surveys that yield 

quantitative results that can be 

generalized to the population of study. 

This feedback will provide insights into 

customer or stakeholder perceptions, 

experiences and expectations, provide 

an early warning of issues with service, 

or focus attention on areas where 

communication, training or changes in 

operations might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between the 

Agency and its customers and 

stakeholders. It will also allow feedback 

to contribute directly to the 

improvement of program management. 

Feedback collected under this generic 

clearance will provide useful 

information, but it will not yield data 

that can be generalized to the overall 

population. This type of generic 

clearance for qualitative information 

will not be used for quantitative 

information collections that are 

designed to yield reliably actionable 

results, such as monitoring trends over 

time or documenting program 

performance. Such data uses require 

more rigorous designs that address: The 

target population to which 

generalizations will be made, the 

sampling frame, the sample design 

(including stratification and clustering), 

the precision requirements or power 

calculations that justify the proposed 

sample size, the expected response rate, 

methods for assessing potential nonresponse bias, the protocols for data 

collection, and any testing procedures 

that were or will be undertaken prior 

fielding the study. Depending on the 

degree of influence the results are likely 

to have, such collections may still be 

eligible for submission for other generic 

mechanisms that are designed to yield 

quantitative results. 

NPPD received no comments in 

response to the 60-day notice published 

in the Federal Register of December 19, 

2013 (78 FR 244). 

Below we provide National Protection 

and Programs Directorate projected 

average estimates for the next three 

years: 

Current Actions: New collection of 

information. 

Type of Review: New Collection. 

Affected Public: Individuals and 

households, businesses and 

organizations, State, Local or Tribal 

Government. 

Estimated Number of Respondents: 

Below is a preliminary estimate of the 

aggregate burden hours for this generic 

clearance. This estimate is based on a 

review of past behavior of the 

participating sub-components and by 

several individual sub-components’ 

estimates for this ICR. In recognition 

that individual sub-components will 

differ in how often they use this generic 

clearance, this burden estimate assumes 

that 2 sub-components would be the 

heaviest users and account for 

approximately ten times as great a 

burden as the other sub-components 

combined. NPPD sub-components will 

provide more refined individual 

estimates of burden in their subsequent 

notices. 

Average Expected Annual Number of 

activities: 15. 

Respondents: 14080. 

Annual responses: 14080. 

Frequency of Response: Once per 

request. 

Average minutes per response: 34 

minutes. 

Burden hours: 7920.3. 

An agency may not conduct or 

sponsor, and a person is not required to 

respond to, a collection of information 

unless it displays a currently valid 

Office of Management and Budget 

control number. 

Dated: May 9, 2014. 

Scott Libby, 

Acting Chief Information Officer, National 

Protection and Programs Directorate, 

Department of Homeland Security. 

[FR Doc. 2014–11389 Filed 5–16–14; 8:45 am] 

BILLING CODE 9110–9P–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2013–0043] 

General Meeting Registration and 

Evaluation 

AGENCY: National Protection and 

Programs Directorate, DHS. 

ACTION: 30-day notice and request for 

comments; new information collection 

request: 1670—NEW. 

SUMMARY: The Department of Homeland 

Security (DHS), National Protection and 

Programs Directorate (NPPD, Office of 

Cybersecurity and Communications 

(CS&C), Office of Emergency 

Communications (OEC), will submit the 

following information collection request 

(ICR) to the Office of Management and 

Budget (OMB) for review and clearance 

in accordance with the Paperwork 

Reduction Act of 1995 (Pub. L. 104–13, 

44 U.S.C. Chapter 35). NPPD is 

soliciting comments concerning New 

Information Collection Request, General 

Meeting Registration and Evaluation. 

DHS previously published this ICR in 

the Federal Register on March 17, 2011, 

at 76 FR 52, for a 60-day public 

comment period. DHS received no 

comments. The purpose of this notice is 

to allow an additional 30 days for public 

comments. 

mstockstill on DSK4VPTVN1PROD with NOTICES